25 XP   0   0   10

Shandong Lukang Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Shandong Lukang Pharmaceutical Co Ltd together

PenkeI guess you are interested in Shandong Lukang Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shandong Lukang Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shandong Lukang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Lukang Pharmaceutical Co Ltd.

Quick analysis of Shandong Lukang Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Shandong Lukang Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.18
Expected worth in 1 year
¥4.44
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥0.42
Return On Investment
6.9%

For what price can you sell your share?

Current Price per Share
¥6.08
Expected price per share
¥5.04 - ¥6.54
How sure are you?
50%

1. Valuation of Shandong Lukang Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.08

Intrinsic Value Per Share

¥-2.20 - ¥12.71

Total Value Per Share

¥1.97 - ¥16.89

2. Growth of Shandong Lukang Pharmaceutical Co Ltd (5 min.)




Is Shandong Lukang Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$516.3m$480m$25.4m5.0%

How much money is Shandong Lukang Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$8.4m$4.7m$3.7m43.9%
Net Profit Margin4.0%2.4%--

How much money comes from the company's main activities?

3. Financial Health of Shandong Lukang Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Shandong Lukang Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Shandong Lukang Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Shandong Lukang Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Shandong Lukang Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Shandong Lukang Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shandong Lukang Pharmaceutical Co Ltd is ¥6.08. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shandong Lukang Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shandong Lukang Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.18. Based on the TTM, the Book Value Change Per Share is ¥0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shandong Lukang Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.2%0.010.1%0.010.1%0.000.1%
Usd Book Value Change Per Share0.010.1%0.010.1%0.000.1%0.010.1%0.010.1%
Usd Dividend Per Share0.000.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.2%0.010.2%0.010.2%0.010.2%0.010.2%
Usd Price Per Share0.99-0.94-0.93-1.04-1.17-
Price to Earnings Ratio29.83-26.34-47.70--15.98-379.99-
Price-to-Total Gains Ratio80.53-66.13-101.74-134.03-135.82-
Price to Book Ratio1.71-1.67-1.73-1.99-3.09-
Price-to-Total Gains Ratio80.53-66.13-101.74-134.03-135.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.83904
Number of shares1191
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (1191 shares)17.3312.20
Gains per Year (1191 shares)69.3248.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1264359242539
25386128484988
3791291977374137
41051722669798186
5132215335121123235
6158258404145147284
7185301473170172333
8211344542194197382
9237387611218221431
10264430680242246480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%33.02.05.082.5%67.02.017.077.9%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%29.011.00.072.5%62.024.00.072.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%81.00.05.094.2%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%37.03.00.092.5%79.07.00.091.9%

Fundamentals of Shandong Lukang Pharmaceutical Co Ltd

About Shandong Lukang Pharmaceutical Co Ltd

Shandong Lukang Pharmaceutical Co.,Ltd. manufactures and sells bio-pharmaceuticals and antibiotics in China. The company offers human and animal active pharmaceutical ingredients; human and animal preparations; bio-pesticides; herbal medicines; and amino acid. It is also involved in the sewage treatment, odor control, sewage facilities management, environmental protection material production and sales, management of water disposal reagents, and environmental protection equipment manufacture and installation. The company also exports its products to European Union, the United States, the United Kingdom, Russia, India, Brazil, and Japan. The company was formerly known as Jining Antibiotic Factory and changed its name to Shandong Lukang Pharmaceutical Co.,Ltd. in October 1993. Shandong Lukang Pharmaceutical Co.,Ltd. was founded in 1966 and is based in Jining, China.

Fundamental data was last updated by Penke on 2024-04-17 10:23:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shandong Lukang Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shandong Lukang Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.8% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 3.8%. The company is making a profit. +1
  • The TTM is 4.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.8%TTM4.0%-0.2%
TTM4.0%YOY2.4%+1.6%
TTM4.0%5Y3.4%+0.6%
5Y3.4%10Y2.8%+0.6%
1.1.2. Return on Assets

Shows how efficient Shandong Lukang Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Shandong Lukang Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.7%-0.1%
TTM0.7%YOY0.4%+0.3%
TTM0.7%5Y0.5%+0.2%
5Y0.5%10Y0.4%+0.1%
1.1.3. Return on Equity

Shows how efficient Shandong Lukang Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.5% Return on Equity means Shandong Lukang Pharmaceutical Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.8%-0.3%
TTM1.8%YOY1.0%+0.7%
TTM1.8%5Y1.2%+0.5%
5Y1.2%10Y1.0%+0.3%

1.2. Operating Efficiency of Shandong Lukang Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shandong Lukang Pharmaceutical Co Ltd is operating .

  • Measures how much profit Shandong Lukang Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.6%-1.6%
TTM1.6%YOY3.6%-2.0%
TTM1.6%5Y3.3%-1.7%
5Y3.3%10Y1.8%+1.5%
1.2.2. Operating Ratio

Measures how efficient Shandong Lukang Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ¥1.61 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 1.612. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.688. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.612TTM1.688-0.076
TTM1.688YOY1.727-0.039
TTM1.6885Y1.704-0.017
5Y1.70410Y1.285+0.419

1.3. Liquidity of Shandong Lukang Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shandong Lukang Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.04 means the company has ¥1.04 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 1.037. The company is just able to pay all its short-term debts.
  • The TTM is 1.039. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.037TTM1.039-0.002
TTM1.039YOY0.823+0.216
TTM1.0395Y0.912+0.127
5Y0.91210Y0.565+0.347
1.3.2. Quick Ratio

Measures if Shandong Lukang Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.23 means the company can pay off ¥0.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 0.228. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.294. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.228TTM0.294-0.066
TTM0.294YOY0.299-0.004
TTM0.2945Y0.272+0.022
5Y0.27210Y0.346-0.074

1.4. Solvency of Shandong Lukang Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shandong Lukang Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.57 means that Shandong Lukang Pharmaceutical Co Ltd assets are financed with 57.5% credit (debt) and the remaining percentage (100% - 57.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 0.575. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.573. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.575TTM0.573+0.002
TTM0.573YOY0.583-0.010
TTM0.5735Y0.558+0.014
5Y0.55810Y0.558+0.001
1.4.2. Debt to Equity Ratio

Measures if Shandong Lukang Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 140.1% means that company has ¥1.40 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The MRQ is 1.401. The company is able to pay all its debts with equity. +1
  • The TTM is 1.398. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.401TTM1.398+0.003
TTM1.398YOY1.462-0.064
TTM1.3985Y1.328+0.070
5Y1.32810Y1.346-0.018

2. Market Valuation of Shandong Lukang Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shandong Lukang Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shandong Lukang Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 29.83 means the investor is paying ¥29.83 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The EOD is 25.401. Based on the earnings, the company is overpriced. -1
  • The MRQ is 29.829. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.336. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD25.401MRQ29.829-4.428
MRQ29.829TTM26.336+3.493
TTM26.336YOY47.703-21.366
TTM26.3365Y-15.978+42.315
5Y-15.97810Y379.987-395.965
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The EOD is 26.854. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 31.536. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -49.445. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.854MRQ31.536-4.682
MRQ31.536TTM-49.445+80.981
TTM-49.445YOY9.289-58.734
TTM-49.4455Y-22.976-26.469
5Y-22.97610Y150.536-173.512
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shandong Lukang Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shandong Lukang Pharmaceutical Co Ltd:

  • The EOD is 1.456. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.710. Based on the equity, the company is underpriced. +1
  • The TTM is 1.667. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.456MRQ1.710-0.254
MRQ1.710TTM1.667+0.043
TTM1.667YOY1.732-0.065
TTM1.6675Y1.991-0.324
5Y1.99110Y3.089-1.098
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shandong Lukang Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0630.065-3%0.030+110%0.037+69%0.059+8%
Book Value Per Share--4.1754.088+2%3.882+8%3.804+10%3.068+36%
Current Ratio--1.0371.0390%0.823+26%0.912+14%0.565+83%
Debt To Asset Ratio--0.5750.573+0%0.583-1%0.558+3%0.558+3%
Debt To Equity Ratio--1.4011.398+0%1.462-4%1.328+6%1.346+4%
Dividend Per Share--0.0250.040-37%0.039-35%0.037-31%0.036-30%
Eps--0.0600.069-13%0.039+55%0.046+31%0.032+90%
Free Cash Flow Per Share--0.0570.074-24%0.004+1167%-0.055+198%-0.086+252%
Free Cash Flow To Equity Per Share--0.0570.052+9%0.003+1795%-0.039+170%-0.011+120%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Intrinsic Value_10Y_max--12.714--------
Intrinsic Value_10Y_min---2.204--------
Intrinsic Value_1Y_max--0.167--------
Intrinsic Value_1Y_min---0.325--------
Intrinsic Value_3Y_max--1.346--------
Intrinsic Value_3Y_min---0.892--------
Intrinsic Value_5Y_max--3.541--------
Intrinsic Value_5Y_min---1.362--------
Market Cap5448020480.000-17%6397839840.0006106621640.000+5%6025976600.000+6%6746405624.000-5%7586014576.280-16%
Net Profit Margin--0.0380.040-6%0.024+55%0.034+12%0.028+38%
Operating Margin---0.016-100%0.036-100%0.033-100%0.018-100%
Operating Ratio--1.6121.688-5%1.727-7%1.704-5%1.285+25%
Pb Ratio1.456-17%1.7101.667+3%1.732-1%1.991-14%3.089-45%
Pe Ratio25.401-17%29.82926.336+13%47.703-37%-15.978+154%379.987-92%
Price Per Share6.080-17%7.1406.815+5%6.725+6%7.529-5%8.466-16%
Price To Free Cash Flow Ratio26.854-17%31.536-49.445+257%9.289+239%-22.976+173%150.536-79%
Price To Total Gains Ratio68.576-17%80.53266.135+22%101.738-21%134.029-40%135.819-41%
Quick Ratio--0.2280.294-22%0.299-24%0.272-16%0.346-34%
Return On Assets--0.0060.007-15%0.004+47%0.005+15%0.004+49%
Return On Equity--0.0150.018-15%0.010+43%0.012+20%0.010+55%
Total Gains Per Share--0.0890.105-16%0.069+28%0.074+19%0.095-7%
Usd Book Value--516306075.863505446232.583+2%480040156.386+8%470327932.907+10%379354941.736+36%
Usd Book Value Change Per Share--0.0090.009-3%0.004+110%0.005+69%0.008+8%
Usd Book Value Per Share--0.5760.564+2%0.536+8%0.525+10%0.423+36%
Usd Dividend Per Share--0.0040.006-37%0.005-35%0.005-31%0.005-30%
Usd Eps--0.0080.009-13%0.005+55%0.006+31%0.004+90%
Usd Free Cash Flow--6999141.6339180162.785-24%552570.277+1167%-6835245.121+198%-10629406.861+252%
Usd Free Cash Flow Per Share--0.0080.010-24%0.001+1167%-0.008+198%-0.012+252%
Usd Free Cash Flow To Equity Per Share--0.0080.007+9%0.000+1795%-0.005+170%-0.002+120%
Usd Market Cap751826826.240-17%882901897.920842713786.320+5%831584770.800+6%931003976.112-5%1046870011.527-16%
Usd Price Per Share0.839-17%0.9850.940+5%0.928+6%1.039-5%1.168-16%
Usd Profit--7399606.2228492927.015-13%4761452.964+55%5630388.971+31%3901751.120+90%
Usd Revenue--195250209.797212061889.664-8%193939745.676+1%169716981.134+15%130258736.080+50%
Usd Total Gains Per Share--0.0120.015-16%0.010+28%0.010+19%0.013-7%
 EOD+4 -4MRQTTM+10 -25YOY+28 -75Y+23 -1210Y+23 -13

3.2. Fundamental Score

Let's check the fundamental score of Shandong Lukang Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1525.401
Price to Book Ratio (EOD)Between0-11.456
Net Profit Margin (MRQ)Greater than00.038
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.228
Current Ratio (MRQ)Greater than11.037
Debt to Asset Ratio (MRQ)Less than10.575
Debt to Equity Ratio (MRQ)Less than11.401
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.006
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Shandong Lukang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.277
Ma 20Greater thanMa 506.047
Ma 50Greater thanMa 1006.118
Ma 100Greater thanMa 2006.570
OpenGreater thanClose6.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,802,431
Total Liabilities5,061,083
Total Stockholder Equity3,611,695
 As reported
Total Liabilities 5,061,083
Total Stockholder Equity+ 3,611,695
Total Assets = 8,802,431

Assets

Total Assets8,802,431
Total Current Assets3,647,794
Long-term Assets5,154,637
Total Current Assets
Cash And Cash Equivalents 798,462
Short-term Investments 1,191
Net Receivables 801,646
Inventory 1,405,981
Other Current Assets 32,603
Total Current Assets  (as reported)3,647,794
Total Current Assets  (calculated)3,039,883
+/- 607,911
Long-term Assets
Property Plant Equipment 3,887,080
Intangible Assets 831,017
Long-term Assets Other 75,447
Long-term Assets  (as reported)5,154,637
Long-term Assets  (calculated)4,793,544
+/- 361,093

Liabilities & Shareholders' Equity

Total Current Liabilities3,517,331
Long-term Liabilities1,543,752
Total Stockholder Equity3,611,695
Total Current Liabilities
Short Long Term Debt 1,102,497
Accounts payable 1,502,638
Other Current Liabilities 31,077
Total Current Liabilities  (as reported)3,517,331
Total Current Liabilities  (calculated)2,636,212
+/- 881,119
Long-term Liabilities
Long term Debt 1,308,926
Long-term Liabilities  (as reported)1,543,752
Long-term Liabilities  (calculated)1,308,926
+/- 234,826
Total Stockholder Equity
Retained Earnings 868,157
Total Stockholder Equity (as reported)3,611,695
Total Stockholder Equity (calculated)868,157
+/- 2,743,538
Other
Capital Stock896,037
Common Stock Shares Outstanding 896,037
Net Debt 1,612,960
Net Invested Capital 6,023,118
Net Working Capital 130,464
Property Plant and Equipment Gross 3,887,080



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
1,822,629
2,269,925
2,354,655
2,405,012
2,433,650
2,375,976
2,274,897
2,361,077
2,392,648
2,764,669
2,784,769
2,696,538
2,736,220
2,776,612
2,767,418
2,698,032
2,762,803
2,726,842
2,689,544
2,585,363
2,605,533
2,572,452
2,496,454
2,428,679
2,431,508
2,435,858
2,449,496
2,509,027
2,627,244
2,643,396
2,596,334
2,501,423
2,572,400
2,536,326
2,521,352
2,478,404
2,672,450
2,838,804
2,931,374
3,025,123
3,112,524
3,377,423
3,554,870
3,481,294
3,770,265
3,833,549
3,916,058
3,985,171
4,104,854
4,286,967
3,948,637
4,074,764
4,196,591
4,113,875
3,995,332
4,084,923
4,047,210
3,992,027
3,963,653
4,018,272
4,025,170
4,034,307
4,044,002
4,178,044
4,402,477
4,780,025
4,779,461
5,201,916
6,395,882
6,584,130
6,503,059
6,567,448
6,828,443
7,072,904
7,058,159
7,089,268
7,329,422
7,157,522
7,010,934
7,272,825
7,544,778
7,414,555
7,593,850
7,789,563
7,986,559
8,256,824
8,428,431
8,727,665
8,548,945
8,337,386
8,608,485
8,802,431
8,802,4318,608,4858,337,3868,548,9458,727,6658,428,4318,256,8247,986,5597,789,5637,593,8507,414,5557,544,7787,272,8257,010,9347,157,5227,329,4227,089,2687,058,1597,072,9046,828,4436,567,4486,503,0596,584,1306,395,8825,201,9164,779,4614,780,0254,402,4774,178,0444,044,0024,034,3074,025,1704,018,2723,963,6533,992,0274,047,2104,084,9233,995,3324,113,8754,196,5914,074,7643,948,6374,286,9674,104,8543,985,1713,916,0583,833,5493,770,2653,481,2943,554,8703,377,4233,112,5243,025,1232,931,3742,838,8042,672,4502,478,4042,521,3522,536,3262,572,4002,501,4232,596,3342,643,3962,627,2442,509,0272,449,4962,435,8582,431,5082,428,6792,496,4542,572,4522,605,5332,585,3632,689,5442,726,8422,762,8032,698,0322,767,4182,776,6122,736,2202,696,5382,784,7692,764,6692,392,6482,361,0772,274,8972,375,9762,433,6502,405,0122,354,6552,269,9251,822,629
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,295,415
3,014,731
2,934,358
2,884,533
2,943,778
2,759,407
2,585,118
2,741,722
2,724,486
2,419,080
2,507,365
2,685,738
2,492,012
2,545,919
2,702,237
2,891,338
3,105,789
3,313,321
3,508,826
3,387,520
3,202,459
3,457,188
3,647,794
3,647,7943,457,1883,202,4593,387,5203,508,8263,313,3213,105,7892,891,3382,702,2372,545,9192,492,0122,685,7382,507,3652,419,0802,724,4862,741,7222,585,1182,759,4072,943,7782,884,5332,934,3583,014,7313,295,415000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,628,965
1,375,230
1,006,874
938,230
1,253,146
996,527
905,102
893,124
936,822
698,134
647,687
597,588
504,122
533,974
554,021
549,657
602,505
693,009
688,811
625,661
614,103
563,797
798,462
798,462563,797614,103625,661688,811693,009602,505549,657554,021533,974504,122597,588647,687698,134936,822893,124905,102996,5271,253,146938,2301,006,8741,375,2301,628,965000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260,000
1,245
1,117
1,048
1,151
1,087
1,070
1,127
1,095
1,031
1,166
1,100
1,208
1,346
1,198
1,196
1,260
1,274
1,321
1,274
1,191
1,1911,2741,3211,2741,2601,1961,1981,3461,2081,1001,1661,0311,0951,1271,0701,0871,1511,0481,1171,245260,00000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
292,060
333,418
495,327
391,631
406,300
385,529
413,383
419,381
438,720
452,363
430,117
361,261
463,455
383,094
449,142
387,453
405,070
395,130
428,407
413,894
475,886
452,999
499,583
460,741
492,776
485,161
482,978
429,543
557,770
503,618
454,285
337,936
438,790
439,848
430,271
392,469
517,608
542,152
667,477
494,544
591,803
627,108
661,142
543,452
749,708
716,132
800,266
714,187
808,965
921,420
783,594
702,054
862,113
791,403
866,208
769,181
820,192
691,015
735,090
713,387
799,950
700,635
657,571
605,256
595,150
614,189
578,375
587,982
772,740
669,941
662,060
747,183
611,008
531,053
515,529
755,455
871,945
837,806
806,860
897,217
906,826
790,108
848,952
842,316
1,117,454
1,179,571
1,083,976
1,250,603
1,164,091
1,022,064
882,775
801,646
801,646882,7751,022,0641,164,0911,250,6031,083,9761,179,5711,117,454842,316848,952790,108906,826897,217806,860837,806871,945755,455515,529531,053611,008747,183662,060669,941772,740587,982578,375614,189595,150605,256657,571700,635799,950713,387735,090691,015820,192769,181866,208791,403862,113702,054783,594921,420808,965714,187800,266716,132749,708543,452661,142627,108591,803494,544667,477542,152517,608392,469430,271439,848438,790337,936454,285503,618557,770429,543482,978485,161492,776460,741499,583452,999475,886413,894428,407395,130405,070387,453449,142383,094463,455361,261430,117452,363438,720419,381413,383385,529406,300391,631495,327333,418292,060
       Other Current Assets 
28,382
28,549
15,580
25,105
29,546
36,639
28,556
14,873
19,010
20,005
28,939
17,789
15,010
32,235
32,551
37,052
38,526
36,365
36,966
25,527
21,658
27,482
32,413
23,041
18,468
21,876
26,695
30,379
46,020
54,377
42,922
28,770
28,846
25,340
66,501
26,898
48,938
81,603
92,976
127,810
125,204
163,153
154,800
144,881
129,905
63,764
72,205
71,113
74,465
76,528
71,788
162,328
165,910
159,114
171,153
88,609
69,680
111,840
79,267
85,747
80,301
82,409
68,485
62,014
73,801
49,793
63,552
70,454
70,355
84,608
67,119
70,445
276,632
13,295
11,097
59,213
70,249
64,341
117,430
92,300
105,596
72,065
90,193
96,303
93,651
81,236
116,875
87,467
92,861
79,220
12,760
32,603
32,60312,76079,22092,86187,467116,87581,23693,65196,30390,19372,065105,59692,300117,43064,34170,24959,21311,09713,295276,63270,44567,11984,60870,35570,45463,55249,79373,80162,01468,48582,40980,30185,74779,267111,84069,68088,609171,153159,114165,910162,32871,78876,52874,46571,11372,20563,764129,905144,881154,800163,153125,204127,81092,97681,60348,93826,89866,50125,34028,84628,77042,92254,37746,02030,37926,69521,87618,46823,04132,41327,48221,65825,52736,96636,36538,52637,05232,55132,23515,01017,78928,93920,00519,01014,87328,55636,63929,54625,10515,58028,54928,382
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,943,910
4,129,126
4,298,752
4,504,150
4,587,700
4,433,035
4,591,854
4,765,460
4,859,040
4,922,542
5,047,930
5,087,326
5,095,221
5,151,035
5,115,110
5,218,840
5,161,425
5,134,927
5,151,297
5,154,637
5,154,6375,151,2975,134,9275,161,4255,218,8405,115,1105,151,0355,095,2215,087,3265,047,9304,922,5424,859,0404,765,4604,591,8544,433,0354,587,7004,504,1504,298,7524,129,1263,943,910000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,237,709
1,363,273
1,392,737
1,518,616
1,506,046
1,508,635
1,518,165
1,613,584
1,637,531
1,645,777
1,649,289
1,716,067
1,727,147
1,721,236
1,723,085
1,715,917
1,694,156
1,685,594
1,650,760
1,637,147
1,594,871
1,581,833
1,538,358
1,537,700
1,481,548
1,462,881
1,421,643
1,408,126
1,365,569
1,414,444
1,369,072
1,397,912
1,333,648
1,352,828
1,295,854
1,305,550
1,256,335
1,283,212
1,245,132
1,332,002
1,352,766
1,549,910
1,528,176
1,738,385
1,687,222
1,906,948
1,824,282
2,032,462
1,848,985
2,037,542
1,808,911
1,938,953
1,703,059
1,684,351
1,654,694
1,738,074
1,696,434
1,670,308
1,639,605
1,701,152
1,702,916
1,713,873
1,707,675
1,801,207
1,795,774
1,923,092
2,209,809
2,347,756
2,391,288
2,670,534
2,761,651
2,698,266
3,037,981
3,007,097
3,101,872
3,244,005
3,298,373
3,358,863
3,614,726
3,749,509
3,756,972
3,760,973
3,791,243
3,858,881
3,842,077
3,901,206
3,945,440
4,046,679
4,037,445
3,925,725
3,786,848
3,887,080
3,887,0803,786,8483,925,7254,037,4454,046,6793,945,4403,901,2063,842,0773,858,8813,791,2433,760,9733,756,9723,749,5093,614,7263,358,8633,298,3733,244,0053,101,8723,007,0973,037,9812,698,2662,761,6512,670,5342,391,2882,347,7562,209,8091,923,0921,795,7741,801,2071,707,6751,713,8731,702,9161,701,1521,639,6051,670,3081,696,4341,738,0741,654,6941,684,3511,703,0591,938,9531,808,9112,037,5421,848,9852,032,4621,824,2821,906,9481,687,2221,738,3851,528,1761,549,9101,352,7661,332,0021,245,1321,283,2121,256,3351,305,5501,295,8541,352,8281,333,6481,397,9121,369,0721,414,4441,365,5691,408,1261,421,6431,462,8811,481,5481,537,7001,538,3581,581,8331,594,8711,637,1471,650,7601,685,5941,694,1561,715,9171,723,0851,721,2361,727,1471,716,0671,649,2891,645,7771,637,5311,613,5841,518,1651,508,6351,506,0461,518,6161,392,7371,363,2731,237,709
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,935
53,785
52,915
53,801
54,646
53,058
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000053,05854,64653,80152,91553,78552,935000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
10,527
10,413
10,300
10,186
10,129
10,073
10,016
13,490
13,420
13,341
13,266
17,628
17,324
63,512
48,884
47,480
46,351
32,477
44,093
43,947
55,350
40,396
53,148
38,312
47,546
36,453
47,098
28,146
46,046
29,245
50,409
26,167
60,424
23,814
60,170
23,862
57,383
21,345
53,750
19,384
118,120
16,796
116,378
17,637
117,879
26,316
192,740
32,142
244,210
28,852
243,053
38,585
223,402
217,721
218,219
216,818
214,216
212,035
210,259
206,904
205,304
228,616
224,936
194,434
192,028
191,498
222,590
219,087
217,278
213,818
221,923
218,502
327,206
144,274
510,913
539,617
543,196
549,959
556,595
574,133
687,417
695,945
707,109
671,838
686,120
748,949
674,077
749,097
747,179
757,130
865,949
831,017
831,017865,949757,130747,179749,097674,077748,949686,120671,838707,109695,945687,417574,133556,595549,959543,196539,617510,913144,274327,206218,502221,923213,818217,278219,087222,590191,498192,028194,434224,936228,616205,304206,904210,259212,035214,216216,818218,219217,721223,40238,585243,05328,852244,21032,142192,74026,316117,87917,637116,37816,796118,12019,38453,75021,34557,38323,86260,17023,81460,42426,16750,40929,24546,04628,14647,09836,45347,54638,31253,14840,39655,35043,94744,09332,47746,35147,48048,88463,51217,32417,62813,26613,34113,42013,49010,01610,07310,12910,18610,30010,41310,527
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
210,886
232,810
288,512
165,547
177,679
185,209
3,703,129
109,511
74,918
92,704
151,834
123,946
119,638
96,067
69,860
92,539
44,600
120,501
144,096
75,447
75,447144,096120,50144,60092,53969,86096,067119,638123,946151,83492,70474,918109,5113,703,129185,209177,679165,547288,512232,810210,886000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
685,252
1,139,451
1,195,464
1,243,276
1,232,313
1,156,845
1,036,622
1,101,720
1,107,665
1,114,142
1,121,021
1,081,637
1,118,405
1,183,579
1,197,884
1,202,660
1,266,181
1,229,952
1,192,803
1,086,917
1,102,317
1,067,138
990,716
1,006,660
1,003,297
1,002,028
1,008,913
1,048,696
1,161,962
1,151,636
1,099,397
1,000,529
1,063,249
1,017,566
998,149
930,376
1,077,428
1,211,013
1,281,327
1,348,476
1,390,745
1,641,979
1,808,576
1,787,725
2,093,809
2,190,896
2,276,939
2,378,214
2,473,269
2,684,546
2,373,545
2,440,004
2,581,226
2,531,409
2,443,924
2,580,702
2,540,343
2,080,302
2,055,932
2,112,992
2,114,574
2,072,464
2,064,171
2,196,054
2,405,241
2,772,337
2,755,875
3,103,104
3,326,004
3,501,650
3,379,192
3,495,822
3,706,084
3,937,419
3,900,761
3,917,628
4,150,289
3,752,174
3,638,998
3,913,555
4,132,485
3,980,285
4,143,535
4,390,365
4,533,580
4,777,133
4,954,062
5,220,497
4,979,764
4,681,945
4,923,841
5,061,083
5,061,0834,923,8414,681,9454,979,7645,220,4974,954,0624,777,1334,533,5804,390,3654,143,5353,980,2854,132,4853,913,5553,638,9983,752,1744,150,2893,917,6283,900,7613,937,4193,706,0843,495,8223,379,1923,501,6503,326,0043,103,1042,755,8752,772,3372,405,2412,196,0542,064,1712,072,4642,114,5742,112,9922,055,9322,080,3022,540,3432,580,7022,443,9242,531,4092,581,2262,440,0042,373,5452,684,5462,473,2692,378,2142,276,9392,190,8962,093,8091,787,7251,808,5761,641,9791,390,7451,348,4761,281,3271,211,0131,077,428930,376998,1491,017,5661,063,2491,000,5291,099,3971,151,6361,161,9621,048,6961,008,9131,002,0281,003,2971,006,660990,7161,067,1381,102,3171,086,9171,192,8031,229,9521,266,1811,202,6601,197,8841,183,5791,118,4051,081,6371,121,0211,114,1421,107,6651,101,7201,036,6221,156,8451,232,3131,243,2761,195,4641,139,451685,252
   > Total Current Liabilities 
436,948
376,764
524,555
680,501
694,704
619,236
499,012
670,145
676,586
710,905
717,827
763,458
800,225
897,946
912,251
972,633
1,038,653
1,047,438
1,010,289
986,917
1,002,317
1,027,138
950,716
961,660
958,297
912,028
918,912
989,866
1,082,132
1,101,326
1,064,031
972,649
1,035,376
979,698
953,286
890,069
1,037,121
1,170,717
1,243,030
1,315,259
1,303,109
1,473,236
1,620,960
1,599,830
1,591,718
1,684,062
1,777,405
1,819,896
1,714,009
1,907,087
1,582,775
1,684,125
1,761,024
1,771,305
1,685,876
1,893,693
1,817,400
1,367,091
1,384,343
1,543,371
1,570,941
1,561,986
1,543,250
1,603,371
1,833,738
1,990,344
1,606,551
1,723,191
1,887,412
2,101,882
2,003,993
2,274,288
2,484,795
2,783,737
2,761,530
3,201,221
3,444,458
3,069,849
2,899,728
3,126,500
3,238,830
2,600,199
2,876,571
3,474,447
3,543,656
3,828,170
4,055,608
4,129,057
3,526,689
3,085,408
3,082,967
3,517,331
3,517,3313,082,9673,085,4083,526,6894,129,0574,055,6083,828,1703,543,6563,474,4472,876,5712,600,1993,238,8303,126,5002,899,7283,069,8493,444,4583,201,2212,761,5302,783,7372,484,7952,274,2882,003,9932,101,8821,887,4121,723,1911,606,5511,990,3441,833,7381,603,3711,543,2501,561,9861,570,9411,543,3711,384,3431,367,0911,817,4001,893,6931,685,8761,771,3051,761,0241,684,1251,582,7751,907,0871,714,0091,819,8961,777,4051,684,0621,591,7181,599,8301,620,9601,473,2361,303,1091,315,2591,243,0301,170,7171,037,121890,069953,286979,6981,035,376972,6491,064,0311,101,3261,082,132989,866918,912912,028958,297961,660950,7161,027,1381,002,317986,9171,010,2891,047,4381,038,653972,633912,251897,946800,225763,458717,827710,905676,586670,145499,012619,236694,704680,501524,555376,764436,948
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,514
0
188,078
850,000
1,064,955
1,137,014
1,057,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,057,0001,137,0141,064,955850,000188,078035,514000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,514
0
188,078
850,000
1,064,955
1,137,014
1,057,000
1,349,500
1,162,783
1,459,503
1,559,832
1,566,480
1,136,476
1,217,072
1,282,373
1,261,267
978,783
1,186,447
1,344,239
1,115,767
1,006,926
965,177
1,102,497
1,102,497965,1771,006,9261,115,7671,344,2391,186,447978,7831,261,2671,282,3731,217,0721,136,4761,566,4801,559,8321,459,5031,162,7831,349,5001,057,0001,137,0141,064,955850,000188,078035,514000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
65,822
122,425
155,784
217,005
216,305
215,028
191,168
260,138
265,767
275,177
331,796
318,912
339,140
320,353
302,463
332,924
352,917
382,946
366,285
358,520
369,224
355,552
328,405
366,207
330,667
332,987
318,005
369,566
421,367
408,551
390,834
336,437
396,014
349,405
304,390
289,830
343,984
429,667
478,660
517,649
496,158
671,110
728,877
640,578
652,200
757,382
871,249
1,019,079
1,005,185
1,018,888
821,031
900,308
997,422
1,007,082
909,111
824,194
795,705
755,263
734,918
664,717
667,476
605,556
574,648
695,343
738,442
815,113
945,790
967,252
1,015,461
988,831
989,900
1,045,836
1,063,025
1,145,189
1,182,104
1,266,230
1,176,730
993,192
942,254
1,154,338
1,140,667
1,024,648
1,130,905
1,170,508
1,274,778
1,434,646
1,431,003
1,611,011
1,639,053
1,302,804
1,437,492
1,502,638
1,502,6381,437,4921,302,8041,639,0531,611,0111,431,0031,434,6461,274,7781,170,5081,130,9051,024,6481,140,6671,154,338942,254993,1921,176,7301,266,2301,182,1041,145,1891,063,0251,045,836989,900988,8311,015,461967,252945,790815,113738,442695,343574,648605,556667,476664,717734,918755,263795,705824,194909,1111,007,082997,422900,308821,0311,018,8881,005,1851,019,079871,249757,382652,200640,578728,877671,110496,158517,649478,660429,667343,984289,830304,390349,405396,014336,437390,834408,551421,367369,566318,005332,987330,667366,207328,405355,552369,224358,520366,285382,946352,917332,924302,463320,353339,140318,912331,796275,177265,767260,138191,168215,028216,305217,005155,784122,42565,822
       Other Current Liabilities 
110,835
127,003
164,699
152,253
173,493
176,966
159,921
161,809
162,621
195,319
196,862
117,256
140,795
192,146
195,341
168,336
191,363
161,634
158,246
132,604
147,030
105,123
99,382
91,053
96,230
112,641
139,507
128,860
159,325
179,271
169,317
140,788
138,157
132,678
152,461
160,294
186,427
166,520
174,090
135,080
149,421
100,746
108,853
119,622
87,588
98,900
95,526
80,837
86,995
112,014
105,209
91,818
237,013
152,521
335,941
353,572
567,958
339,015
533,789
323,251
657,614
350,024
662,167
322,562
329,889
335,935
304,495
334,653
421,051
295,565
337,553
319,522
333,346
333,710
10,148
299,704
231,398
336,448
270,549
268,120
390,732
305,234
503,522
243,418
325,330
200,384
381,871
386,566
542,855
520,430
32,274
31,077
31,07732,274520,430542,855386,566381,871200,384325,330243,418503,522305,234390,732268,120270,549336,448231,398299,70410,148333,710333,346319,522337,553295,565421,051334,653304,495335,935329,889322,562662,167350,024657,614323,251533,789339,015567,958353,572335,941152,521237,01391,818105,209112,01486,99580,83795,52698,90087,588119,622108,853100,746149,421135,080174,090166,520186,427160,294152,461132,678138,157140,788169,317179,271159,325128,860139,507112,64196,23091,05399,382105,123147,030132,604158,246161,634191,363168,336195,341192,146140,795117,256196,862195,319162,621161,809159,921176,966173,493152,253164,699127,003110,835
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,221,289
1,153,682
1,139,231
716,407
705,831
682,325
739,270
787,055
893,654
1,380,086
1,266,964
915,918
989,924
948,963
898,454
1,091,440
1,453,075
1,596,537
1,840,874
1,543,752
1,543,7521,840,8741,596,5371,453,0751,091,440898,454948,963989,924915,9181,266,9641,380,086893,654787,055739,270682,325705,831716,4071,139,2311,153,6821,221,289000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-35,514
0
-188,078
-850,000
-1,064,955
-1,137,014
-1,057,000
0
52,649
48,408
0
0
0
0
616
616
616
616
0
0
0
0
0
00000616616616616000048,40852,6490-1,057,000-1,137,014-1,064,955-850,000-188,0780-35,514000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
748,933
732,557
9,904
97,697
93,934
500,963
0
2,798
138,131
0
125,773
0
123,858
0
0
0
0
0
0
0
0000000123,8580125,7730138,1312,7980500,96393,93497,6979,904732,557748,933000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,132
66,286
82,255
111,188
134,883
148,560
159,529
164,202
169,732
178,124
187,171
195,845
198,912
207,446
170,170
183,252
162,323
184,726
148,576
155,884
0
0
0
000155,884148,576184,726162,323183,252170,170207,446198,912195,845187,171178,124169,732164,202159,529148,560134,883111,18882,25566,28658,132000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,137,377
1,130,474
1,159,192
1,161,735
1,176,171
1,219,131
1,238,275
1,259,357
1,284,983
1,650,527
1,663,749
1,614,900
1,617,815
1,593,033
1,569,534
1,495,371
1,496,623
1,496,890
1,496,741
1,498,446
1,503,216
1,505,314
1,505,738
1,421,339
1,427,491
1,433,094
1,439,833
1,459,506
1,464,402
1,471,439
1,476,340
1,480,215
1,487,528
1,496,376
1,499,681
1,524,249
1,569,994
1,601,726
1,622,709
1,648,648
1,692,472
1,705,179
1,715,163
1,662,772
1,632,274
1,591,418
1,554,597
1,518,646
1,520,784
1,493,127
1,466,675
1,527,517
1,508,636
1,477,582
1,449,723
1,408,811
1,410,851
1,815,491
1,811,181
1,810,198
1,813,990
1,839,052
1,854,482
1,855,300
1,868,458
1,875,673
1,887,238
1,957,906
2,923,346
2,932,619
2,933,350
2,927,216
2,975,520
2,987,560
3,007,496
3,021,159
3,027,199
3,251,856
3,216,861
3,213,976
3,265,525
3,286,887
3,302,477
3,254,031
3,306,695
3,332,262
3,326,090
3,356,856
3,417,142
3,500,781
3,526,938
3,611,695
3,611,6953,526,9383,500,7813,417,1423,356,8563,326,0903,332,2623,306,6953,254,0313,302,4773,286,8873,265,5253,213,9763,216,8613,251,8563,027,1993,021,1593,007,4962,987,5602,975,5202,927,2162,933,3502,932,6192,923,3461,957,9061,887,2381,875,6731,868,4581,855,3001,854,4821,839,0521,813,9901,810,1981,811,1811,815,4911,410,8511,408,8111,449,7231,477,5821,508,6361,527,5171,466,6751,493,1271,520,7841,518,6461,554,5971,591,4181,632,2741,662,7721,715,1631,705,1791,692,4721,648,6481,622,7091,601,7261,569,9941,524,2491,499,6811,496,3761,487,5281,480,2151,476,3401,471,4391,464,4021,459,5061,439,8331,433,0941,427,4911,421,3391,505,7381,505,3141,503,2161,498,4461,496,7411,496,8901,496,6231,495,3711,569,5341,593,0331,617,8151,614,9001,663,7491,650,5271,284,9831,259,3571,238,2751,219,1311,176,1711,161,7351,159,1921,130,4741,137,377
   Common Stock
364,754
364,754
364,754
364,754
364,754
364,754
364,754
364,754
364,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
411,754
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,575
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
581,576
677,100
677,100
677,100
677,100
677,100
880,230
880,230
880,230
880,230
880,230
880,230
880,230
880,230
880,230
880,261
880,599
881,634
882,206
884,036
886,884
888,873
0
0
0
000888,873886,884884,036882,206881,634880,599880,261880,230880,230880,230880,230880,230880,230880,230880,230880,230677,100677,100677,100677,100677,100581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,576581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575581,575411,754411,754411,754411,754411,754411,754411,754411,754411,754411,754411,754411,754411,754411,754364,754364,754364,754364,754364,754364,754364,754364,754364,754
   Retained Earnings 
127,455
111,589
141,809
133,784
148,219
166,013
185,157
216,762
241,892
256,491
269,669
220,016
222,931
198,148
174,650
102,963
104,483
105,092
105,364
107,939
112,753
114,872
115,297
11,068
15,220
22,923
29,662
37,094
41,990
60,294
67,448
67,332
72,279
77,515
81,771
104,912
152,155
186,747
208,069
234,523
278,009
290,958
302,648
249,536
218,631
178,075
141,750
104,596
107,141
80,617
53,655
115,454
247,304
216,042
187,331
140,846
143,738
141,417
141,595
148,744
152,938
161,597
177,027
177,846
191,003
198,219
209,783
280,451
371,127
403,430
404,161
421,524
319,222
331,261
351,198
514,377
518,132
742,789
704,954
702,643
752,188
772,944
786,319
736,916
781,505
803,963
784,406
849,261
894,949
816,208
828,485
868,157
868,157828,485816,208894,949849,261784,406803,963781,505736,916786,319772,944752,188702,643704,954742,789518,132514,377351,198331,261319,222421,524404,161403,430371,127280,451209,783198,219191,003177,846177,027161,597152,938148,744141,595141,417143,738140,846187,331216,042247,304115,45453,65580,617107,141104,596141,750178,075218,631249,536302,648290,958278,009234,523208,069186,747152,155104,91281,77177,51572,27967,33267,44860,29441,99037,09429,66222,92315,22011,068115,297114,872112,753107,939105,364105,092104,483102,963174,650198,148222,931220,016269,669256,491241,892216,762185,157166,013148,219133,784141,809111,589127,455
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 000-8,841-9,594-7,306-7,306-5,580-5,580-2,392-2,392-992-9920000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,146,721
Cost of Revenue-4,631,268
Gross Profit1,515,4531,515,453
 
Operating Income (+$)
Gross Profit1,515,453
Operating Expense-5,754,147
Operating Income392,574-4,238,694
 
Operating Expense (+$)
Research Development352,280
Selling General Administrative633,970
Selling And Marketing Expenses0
Operating Expense5,754,147986,250
 
Net Interest Income (+$)
Interest Income8,942
Interest Expense-79,175
Other Finance Cost-3,921
Net Interest Income-74,155
 
Pretax Income (+$)
Operating Income392,574
Net Interest Income-74,155
Other Non-Operating Income Expenses0
Income Before Tax (EBT)272,975392,574
EBIT - interestExpense = -79,175
246,172
325,346
Interest Expense79,175
Earnings Before Interest and Taxes (EBIT)0352,150
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax272,975
Tax Provision-16,188
Net Income From Continuing Ops256,787256,787
Net Income246,172
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net074,155
 

Technical Analysis of Shandong Lukang Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shandong Lukang Pharmaceutical Co Ltd. The general trend of Shandong Lukang Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shandong Lukang Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shandong Lukang Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6.06 < 6.54 < 6.54.

The bearish price targets are: 5.67 > 5.04 > 5.04.

Tweet this
Shandong Lukang Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shandong Lukang Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shandong Lukang Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shandong Lukang Pharmaceutical Co Ltd. The current macd is -0.06230446.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Lukang Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shandong Lukang Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shandong Lukang Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shandong Lukang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShandong Lukang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shandong Lukang Pharmaceutical Co Ltd. The current adx is 21.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shandong Lukang Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Shandong Lukang Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shandong Lukang Pharmaceutical Co Ltd. The current sar is 5.74350639.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shandong Lukang Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shandong Lukang Pharmaceutical Co Ltd. The current rsi is 50.28. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Shandong Lukang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShandong Lukang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shandong Lukang Pharmaceutical Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Lukang Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shandong Lukang Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShandong Lukang Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shandong Lukang Pharmaceutical Co Ltd. The current cci is 11.37.

Shandong Lukang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShandong Lukang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shandong Lukang Pharmaceutical Co Ltd. The current cmo is 8.91533864.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shandong Lukang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShandong Lukang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shandong Lukang Pharmaceutical Co Ltd. The current willr is -25.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shandong Lukang Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shandong Lukang Pharmaceutical Co Ltd Daily Williams %R ChartShandong Lukang Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shandong Lukang Pharmaceutical Co Ltd.

Shandong Lukang Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shandong Lukang Pharmaceutical Co Ltd. The current atr is 0.14384755.

Shandong Lukang Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShandong Lukang Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shandong Lukang Pharmaceutical Co Ltd. The current obv is 393,090,235.

Shandong Lukang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShandong Lukang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shandong Lukang Pharmaceutical Co Ltd. The current mfi is 48.16.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Shandong Lukang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShandong Lukang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shandong Lukang Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Shandong Lukang Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shandong Lukang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.277
Ma 20Greater thanMa 506.047
Ma 50Greater thanMa 1006.118
Ma 100Greater thanMa 2006.570
OpenGreater thanClose6.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shandong Lukang Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shandong Lukang Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shandong Lukang Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shandong Lukang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Lukang Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shandong Lukang Pharmaceutical Co Ltd.

Receive notifications about Shandong Lukang Pharmaceutical Co Ltd in your mailbox!